Ticker LaunchReverse merger · Completed · PALI
Leading BioSciences, Inc.
Reverse merger with Seneca Biopharma, Inc. (SNCA)
Leading BioSciences, Inc. merged into Seneca Biopharma, Inc. (SNCA), a Nasdaq-listed clinical-stage biopharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Dec 16, 2020 and closed on Apr 27, 2021. The combined company trades as Palisade Bio, Inc. (PALI) on Nasdaq.
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic to address gastrointestinal function interruption following major surgery.
- Status
- Completed
- Private company
- Leading BioSciences, Inc.
- Public company
- Seneca Biopharma, Inc. (SNCA)
- Public company business before
- Nasdaq-listed clinical-stage biopharmaceutical company
- Announced
- Dec 16, 2020
- Closed
- Apr 27, 2021
- Combined company
- Palisade Bio, Inc. (PALI)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Contingent value rights (CVR)
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Apr 27, 2021
- Closing press release / exhibit
- All filings on EDGAR CIK 1357459
Other completed reverse mergers
- Kun Peng International Holding Limitedinto CX Network Group, Inc. · May 17, 2021
- Healthcare Solutions Holdings, Inc.into Verity Corp. · Apr 21, 2021
- MyMD Pharmaceuticals (Florida), Inc.into Akers Biosciences, Inc. · Apr 16, 2021
- 374Water Inc.into PowerVerde, Inc. · Apr 16, 2021
- StemoniX, Inc.into Cancer Genetics, Inc. · Mar 30, 2021
- Brooklyn ImmunoTherapeutics LLCinto NTN Buzztime, Inc. · Mar 25, 2021